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l’wen~sevea p tients (mean age 57 f 7 years) underwent 
sargety for control of burnt d~~~~cto~ vent~c~- 
lar ~c~ya~~~rn~s (Mnifo~ vent~c~tar ~c~y~~dta 
alone in 9 patients, ve~~~~ar ~c~~~ia and vent~cutar 
fibrillation in 15 and veutricular fibrillation alone in 3) 
within 2 months of acute myocardial infarction. The mean 
number of major arrbytbmic episodes per patient was 15 
(range 2tr 3@) and of drug failuures 4 f 2. Left ven~c~la~ 
~~ was severely impair in the ~0~~ (Eros 
fraction 2%; range 14% to 47%) and 18 patter& (66%) 
bad a leh ventricular aneurysm. 
Endocardial resectloa guided by a combination ofen- 
docardial ctivation mapping during tacltycaldia and frag- 
mentation mapping during sinus rh~m was ~~0~~ in 
all patients. Ait el~~l~ avowal leg vent~cular en- 
The benefits ofsurgery for patients with recurrent monomor- 
phic ventricular tachycardia when performed >6 months 
(late) after acute myocardial infarction are well established 
(l-6). Some patients, however, present with medically re- 
fractory arrhythmias within this time period (early) and the 
role of surgery for them is controversial (4,7-g). ~though 
the anatomic basis for early and late arrhythmias is probably 
similar, surgery has been considered less appropriate even 
for monomorphic ventricular tachycardia in this early time 
period because ofhigh perioperative mortality rates reported 
in several series (10-12). Recent reports (13-15) of improved 
surgical results in such patients probably reflect advances in
myocardial preservation techniques and in intraoperative 
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docardium was excised. Eight patients (29.6%) di 
er early fmstoperattve mo
did those undergoing pl
During a followup peri 
nency, which in turn relates to the risk of 
death. 
electrophysiologic mapping. There are additional problems 
for patients presenting early with drug-refractory ventricalar 
fibrillation or polymorphic ventricular tachycardia. Mapping 
and surgical strategies are less well developed for such 
a~h~rnias. happing local myocardial electrograms during 
sinus rhythm (fra~entation mappings has been implant in 
our approach to the problem of guiding arrhythmia surgery 
in these patients (16-19). This report describes 27 consecu- 
tive patients who underwent surgery at our unit for control 
of recurrent ventricular tachyarrhythmias within 2 months of 
myocardial infarction. 
Study patients. Between September 1981 and October 
1988, surgery was offered to all patients presenting with 
life-t~eateni~g, drug-refractor ventricular tac~yarrb~h- 
mias regardless of proximity of recent myocardiai infarction. 
No patient was refused surgery because of type of ventric- 
ular arrhythmia, nd even severe left ventricular impairment 
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rarely tested. 
Coronary angiography and ve~tri~u~ography wereper- 
formed preoperatively. ~~g~~fi~ant coronary artery stenosis 
was deffined as ~45% ~~rn~~a~ 
ejection fraction was calculate 
oblique ~ineangiograp~ic rojectlon 
stimulation was routinely performed after 
cept in patients in whom a~t~arrhythmi~ 
Mapping was tlot perfo 
tachycardia was associated with cell 
patients and was no~sustai~ed in one. 
was arbitrarily defined as surge 
previous 24 h and performed because of frequently recurring 
or incessant arrhythmias. The remaining operations were 
planned and, although urgently required, were undertaken 
wi 24 h notice. 
sthetic policy. Changes in anesthesia nd bypass 
techniques occurred uring this study, so there was no 
~t~~ope~~tive electrs siologic 
had 53 point epicardial mapping performed insinus rhyt 
during normothermic cardiopulmonary b pass. In patients 
whose spontaneous arrhythmias included episodes of mono- 
morphic ventricular tachycardia, ttempts were made to 
initiatl: the arrhythmia by programmed lectrical stim 
tion. Up to three xtrastimuli w th a drive cycle length of 
or 300 ms were used. Isoproterenol was not used to facilitate 
arrhythmia induction. If stable tachycardia was induced, 
epicardial ctivation mapping was performed to distinguish 
macro- from microreentrant ventricular tachycardia (20). 
After left ventriculotomy 36 point endocardial mappi 
during sinus rhythm was performed in all patients and, 
ventricular tachycardia was inducible, an activation m 
was obtained uring the arrhythmia. Mapping was per- 
~~~~~~~t~~ec~o~y was unkr’sken for areas of left ven- 
tricular scar with dys~i~etic systolic 
ve~tricwlograpby andconfirmed at su 
ere repaired using Tenor-buttressed sutures, with- 
Ity. Coronary bypass grafting was then performe 
mtive care. If necess , intraaortic balloon 
sation was used to as ventricular function. 
Cardiac rhythm was continuously recorded until the predis- 
charge lectrophysiologic study, which was performed using 
e. information regarding the pa- 
tients’ progress after discharge was complete and was de- 
rived from outpatient evaluations or the patient’s prima 
S. Subgroup comparisons are made us- 
ing Student’s unpaired t and chi-square t sts and survival 
curves by Gehan-Wilcoxon testing. 
sit@& 
am Y- T n was anterior in 24 pa- 
tients (89%), inferior in 2 and posterior in 1 patient. Five 
patients (19%) had had a previous infarction, The mean left 
ventricular ejection fraction was 29% (range 14% to 47%) 
and the mean end-diastolic pressure 18 mm Ng (range 3to 
30). Eighteen patients (67%) bad a left ventricular neurysm. 
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r the index infarction. The 
ventricular fibrill 
fibrillation alone. 
patient bad evidence of re~~fa~ct~o~ in association wit 
changes. 
Emergency surgery wns required in 
patients. Ten (37%) of these 14 patients 
electrical stimulation was performed in 12 patients; eight of 
the studies were performed with the patient on antiarrhyth- 
mic drugs. The clinical arrhythmia was induced in 10 pa- 
tients (83%). Despite being noninducible, arrhythmia subse- 
quently recurred in two patients. Programmed electrical 
stimulation was not performed in the remaining 15 patients 
because of recurrent arrhythmias. 
Intraoperativeiy, before the first endocardial resection, 
sustained monomorphic ventricular tachycardia could be 
induced in only 14 (52%) of the 24 patients who had this 
arrhythmia preoperatively. It was induced in a further two 
patients later during surgery. Surgery was therefore guided 
tation mapping during sinus rhythm in 1 I 
rammed electrical stimulation was re- 
ients, and arrhythmia was induced in 3. 
ad further antiarrhythmic procedures 
performed and guided by activation mapping; in two of these 
patients, the arrhythmia was macroreentrant. 
At the end of all antiarrhythmic procedures, while the 
patient was on normothermic bypnss, sustained tachyar- 
Operative Procedure 
Efldocardial reseclion of left ventricle 
Additiona: antiarrbythmic procedures 
A~eurysmectomy 0: infarctectomy 
Ventriculotomy 
Cryoablation 
Endocardial resection of right ventricle 
Additirnal procedures 
Coronary artery bypass grafting 
Mitral valve replacement 
Ventricular septal repair 
ean total cardiopulmonary bypass time 
ean coronary ~ri~~ts/palient receiving grafls 
No. (%) 
27 f mo, 
I# (67) 
3 (II) 
5 (191 
I 14) 
18 (67) 
2 (7) 
I (4) 
I67 min (range 96-249, 
3 
implantable defibrillator. Details of the surgical procedures 
(one preoperatively, 
tively). Eight patients 
seven died of cardiac 
to hypoglycemia. De 
Those who died, however. had a shorter iflterval from 
infarction to arrhythmia onset. Outcome in the first 30 days 
after surgery for those undergoing emergency (n = 14; 
mortality rate 42.8%) versus planned surgery (n = 13; 
Table 3. Comparison of Preoperative Variables in Those 
Surviving and Not Surviving the First 30 
Nonsurvivors Survivor5 p 
(n = 8) (n = 19) Value 
Age (yrl 
Time from MI to VA onset (days) 
Time from MI IO surgery (days1 
LVEF (%) 
Presence of LV aneurysm 
Total bypass time (min) 
Arrhythmia type 
SusVT alone 
SusVT + VF 
VF alone 
Emergency surgery 
Abbreviations as in Table I. 
59 5 4 56 2 8 NS 
825 182 II <0.025 
31 + 17 37 ? I7 NS 
28 + 9 30 2 10 NS 
4 (50%) 14 (74%) NS 
158 r 34 I71 c 51 NS 
2 (25%) 
5 (62.5%) 
I (12.5%) 
6 (75%) 
6(32%) NS 
II (58%) MS 
2 (10.5%) NS 
8 (42%) NS 
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Table 4. Characteristics of Patients in“Planned” and 
“Emergency” Surges ~abgroups 
Planned Emergency p 
In = 13) tn = 14) Value 
Age ivr) _ .- 
Time from MI to VA onset (days) 
Time from MI to surgery (days) 
No. of VA episodes 
LVEF (%I 
Presence of LV An 
Coronary artery disease 
Single vessel 
Double vessel 
Triple vessel 
Arrhythmia type 
SusVT alone 
SusVT + VF 
VF alone 
18 ” IO 
402 I2 
723 
33 rt 9 
9 (6%) 
4 (31%) 
I (8%) 
8 (61%) 
3 (23%) 
9 (6%) 
i(8%) 
13 -c IO 
31 f 19 
22 2 51 
25 + 9 
9 (64%) 
6 (43%) 
7 (50%) 
1(7%) 
5 (36%) 
7 (50%~ 
2 (lP%t 
NS 
NS 
NS 
co.05 
NS 
NS 
co.05 
-co.01 
NS 
NS 
NS 
Abbreviations as in Table I. 
mortality rate l5.4%, p = 0.097), although not statistically 
significant, was strikingly different (Table 4). 
Two of the eight early deaths occurred in the operating 
room. In both cases the patient had required emergency 
operation, and one patient was transferred tothe operating 
room during cardiac arrest. The remaining six early deaths 
occurred in the intensive care unit. The mean stay in the 
intensive care unit for these six patients was 12 days (range 
4 to 22). No patient died during the interval from intensive 
care discharge tohospit~ discharge. The mean length of stay 
in the intensive care unit in operative survivors was 8 days 
(range <24 h to 17) and the total postoperative hospital stay 
was 17 days (range 11 to 37). One patient sustained a left 
hemiparesis during surgery, but made a satisfactory ecov- 
ery. 
Left vent~~cu~ur ejection fraction was measured in 11 of 
19 operative survivors by gated blood pool scanning postop- 
eratively, and the mean value was 28 + 8%. 
Folfow-up. Over a median follow-up eriod of 31 months 
(range 4.5 to 65), there have been two deaths (one at 4.5 
months after surgery from ~inf~ction and one at 24 months, 
after cardiac transplantation). The 1 year survival rate in 
patients discharged alive was therefore 95%. Actuarial sur- 
vival curves are shown in Figure 1. No patient died of 
ventricular rhythmias fter surgery. 
Of the 17 patients alive, 13 (76%) were in New York 
Heart Ass~iation functional c ass I or II and 4 were in class 
III at last review. The cause of limitation in one was lower 
limb claudication. Thirteen patients are taking a diuretic 
drug and 5 an angiotensin-conveying e zyme inhibitor. 
Postoperative ventricular rhythmias. Thirteen of 19 op 
erative survivors underwent electrophysiologic testing be- 
fore hospital discharge, and no arrhythmias were induced. 
% 
S 
U 
R 
V 
04r, 
36 
i t i @ I i 
6 12 18 24 30 36 
days 
Figure 1. Kaplan-Meier survival curves for the total group (n = 27) 
1 and “emergency” (n= 14) 
Programmed stimulation was not performed inthe remaining 
six patients because ofheart failure in four, reso~vio~ ltemi- 
plegia in one and intraoperative noninducibility of arrhyth- 
mia hi one. 
Three patients had episodes of sustained ventricular 
tachycardia orfibrillation before hospital discharge; all sur- 
vived. One a~hythmia was rendered noninducible by amio- 
darone. one patient was treated with amiodarone when 
ventricular fibrillation recurred espite two negative lectro- 
physiologic tests and the third patient was discharged with- 
out antiarrhythmic therapy after negative results from pro- 
grammed stimulation. 
One patient (whose p~mary indication for surgery was 
severe mitral regurgitation after infarction) presented with 
well tolerated sustained ventricular tachycardia 10 weeks 
after surgery. The tachycardia occurred espite negative 
predischarge el ctrophysiologic test results and was consid- 
ered a recurrence of her preoperative arrhythmia. The 
arrhythmia was rendered noninducible by amiodarone, 
which had been ineffective inadequate doses preoperatively. 
Thus, all ~sto~ratjve su~ivors are free of the life- 
threatening ventricular arrhythmias for which surgery was 
recommended (16 with surgery alone and 3 [16%] with 
surges and antia~hythmic drug therapy). 
Patients with recurrent sustained ventricular tachycardia 
or fibrillation early after myocardial infarction are at high 
risk of sudden death. “Natural history” studies (3,5) report 
that the mortality rate is 50% to 100% at B year in such 
patients and that this prognosis not improved by antiar- 
rhythmic drug therapy. 
JACC Vol. 16. No. B 
July 1990:42-8 
BWRKE ET AL. 
ARR LY AFTER lNFARCTlON 
individual patient may be 
s~brn~tti~g patients o surgery o
need rather than on 
by comparing it with the 
Seen in this context, a su 
a planned operation compares favorably with mortality rates 
reported for other surgical series (13-H) in patients within 4 
months of acute myocardial infarcti n. Perhaps urgery for 
these patients can be performed wit greater safety if it can 
be delayed with the help of intraaortic balloo 
ventricular assist device. Our impression, however, is that 
unless further arrhythmic episodes were prevented, little 
would be gained. Indeed, it may be that patients were 
disadvantaged by repetitive drug trials and frequent resusci- 
tations. Patients who survived the first 30 days had a low 
mortality rate in the subsequent 36 months whether surgery 
had been performed as an emergency orelectively. 
The total number of major arrhythmic episodes in these 
patients is less impressive than the frequency with which 
they recurred. It is the frequency of the arrhythmic episodes 
that makes other nonpharmacologic treatments for arrhyth- 
mia control ess applicable to this type of patient. Cardiac 
transplantation rarely can be deployed rapidly enough to be 
useful in this group, and arrhythmia recurrence rates were 
too high for currently available implantable cardioverter- 
defibrillator devices. 
~~traQ~erat~ve ma ing. lntraoperative fragmentation 
output states; and a new arrhythmia created by surgery. Not 
all arrhythmias in the postoperative p riod, therefore, re 
resent failure of surgery, and some do not even justi 
dl-ug-refractory life-threatening ventricular tachyarrhyth- 
mias is an important management op ion for patients, even if 
required within 2 months of acute myocardial infarction. 
Surgery offers arrhythmia cure and return to a good func- 
tional status at an operative risk proportional tothe patient’s 
preoperative arrhythmia frequency and, thus, to the risk of 
arrhythmic death. 
The optimal management strategy for patients with recent 
infarction who present with lcpetitive life-threatening ven- 
tricular tachyarrhythmias is unknown. Drugs, implantable 
devices and surgery probably each have a role. Unfortu- 
nately, at present, hey are often portrayed as competing 
treatments. Antiarrhythmic surgery carries an appreciable 
risk, and improved surgical results may depend less on new 
intraoperative strategies as on the patient’s reaching the 
operating room before multiple resuscitations and c~rn~~a- 
tive drug toxicity have taken their toll. 
mapping during sinus rhythm is a controversial technique 
(22). Although most would acknowledge that it identifies 
local areas of electrophysiologic abnormality, fragmented 
electrograms can be found in areas remote from the activa- 
We thank Sheila Jamieson and Lorna Harker for their help in collating data 
and John Matthews. PhD and Alan Murray, PhD for their statistical help and 
advice. 
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